Popular on Rezul
- Elmington Residential Acquires 260-Unit Workforce Housing Community in Atlanta, GA - 381
- Mesa West Capital Provides $61.5 Million Loan to Finance Silicon Valley Office Property - 319
- Okaloosa Recovery Centers Combine Oct. 26: What Niceville, Shalimar and FWB Homeowners Should Know - 228
- Market Report Q3 2026| Houston Citywide Office - 204
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration - 176
- Brookfield Kolter Land Partners debuts Solaeris master-planned community in Port St. Lucie - 159
- Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 156
- David Weekley Homes' Atlanta Division Has Third Forsyth County Community in the Works - 146
- Canada's First Data Lakehouse Goes Global in Banking: Nabil Bank Becomes Nepal's First Bank to Implement a True Agentic Lakehouse Platform, DataNature - 144
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP - 129
Similar on Rezul
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Kitchen Table Economics: An Invitation to Think Differently
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
Rezul News/10745653
The flagship International Symposium on Medical AI will bring clinicians, AI scientists and scholars together on 3-4 December to address evidence, patient safety, clinical judgement and governance.
FLORENCE, Italy - Rezul -- The International Society of Medical AI (ISMAI), an independent, clinician-led international medical AI society, will convene clinicians, AI scientists, researchers and scholars on 3-4 December 2026 for the International Symposium on Medical AI (ISMAI 2026), its flagship scientific meeting.
Hosted at the Aula Magna, Careggi University Hospital, the symposium will examine how artificial intelligence is entering clinical medicine and what this means for evidence, patient safety, clinical judgement, ethics, governance and professional responsibility.
Under the theme The Renaissance of Clinical Intelligence, the programme places the clinical consequences of medical AI at the centre of the discussion.
More on Rezul News
Confirmed faculty include Edward H. Shortliffe, Vimla L. Patel, Ewout W. Steyerberg, Niels Peek, Laure Wynants, Kerstin Denecke, Giovanni Sartor and Iain Buchan, alongside clinicians, scientists, ethicists, legal scholars and healthcare leaders from several countries.
"Artificial intelligence is entering clinical practice faster than medicine has established common approaches to evidence, oversight and responsibility," said Dr Omar Tujjar, President of the International Society of Medical AI. "The central questions are what evidence should be required, what must remain under professional judgement, and how responsibility should work when AI becomes part of care."
The scientific programme covers foundations of medical AI; clinical AI implementation; validation and patient safety; ethics and philosophy; healthcare AI governance; and medical AI education.
Sessions will address clinical validation, algorithm monitoring, failure reporting, accountability, regulation, human judgement and the implementation of AI across the patient pathway.
More on Rezul News
ISMAI 2026 is clinician-led and vendor-neutral. Scientific programming, faculty selection, abstract review and accreditation are separated from commercial influence.
The symposium carries 12 CME / CPD credits. Abstract submissions across clinical, scientific, ethical, technical and governance themes remain open until 20 October 2026.
Further information: https://florence.ismai.org
About the International Society of Medical AI
The International Society of Medical AI (ISMAI) is an independent, clinician-led, vendor-neutral medical AI society and registered charity in Ireland (RCN 20206982), focused on the safe, evidence-based, ethical and responsible implementation of artificial intelligence in medicine. ISMAI organises the International Symposium on Medical AI, its flagship scientific meeting, bringing together clinicians, AI scientists, researchers, ethicists, legal scholars, policymakers and healthcare leaders.
Hosted at the Aula Magna, Careggi University Hospital, the symposium will examine how artificial intelligence is entering clinical medicine and what this means for evidence, patient safety, clinical judgement, ethics, governance and professional responsibility.
Under the theme The Renaissance of Clinical Intelligence, the programme places the clinical consequences of medical AI at the centre of the discussion.
More on Rezul News
- Phoenix Brokers Brad and Sher Kelley Earn Seniors Real Estate Specialist® Designation
- Mesa West Capital Originates $58.7 Million Loan for Industrial Portfolio Refinance in Glendale, AZ
- Treasure Coast, Florida Real Estate Forecast 2026-2027
- Prices Are Coming Down: Ten High Desert Properties Show Big Price Cuts
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
Confirmed faculty include Edward H. Shortliffe, Vimla L. Patel, Ewout W. Steyerberg, Niels Peek, Laure Wynants, Kerstin Denecke, Giovanni Sartor and Iain Buchan, alongside clinicians, scientists, ethicists, legal scholars and healthcare leaders from several countries.
"Artificial intelligence is entering clinical practice faster than medicine has established common approaches to evidence, oversight and responsibility," said Dr Omar Tujjar, President of the International Society of Medical AI. "The central questions are what evidence should be required, what must remain under professional judgement, and how responsibility should work when AI becomes part of care."
The scientific programme covers foundations of medical AI; clinical AI implementation; validation and patient safety; ethics and philosophy; healthcare AI governance; and medical AI education.
Sessions will address clinical validation, algorithm monitoring, failure reporting, accountability, regulation, human judgement and the implementation of AI across the patient pathway.
More on Rezul News
- Niceville, Shalimar and Fort Walton Beach Sellers: Buyers Have Plenty of Homes to Choose From
- Rates at an 18-year high and values falling: why 1 July 2027 puts new land in focus
- Spencer Buys Houses Expands Cash Home Buying Services in Memphis to Help Local Homeowners
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
ISMAI 2026 is clinician-led and vendor-neutral. Scientific programming, faculty selection, abstract review and accreditation are separated from commercial influence.
The symposium carries 12 CME / CPD credits. Abstract submissions across clinical, scientific, ethical, technical and governance themes remain open until 20 October 2026.
Further information: https://florence.ismai.org
About the International Society of Medical AI
The International Society of Medical AI (ISMAI) is an independent, clinician-led, vendor-neutral medical AI society and registered charity in Ireland (RCN 20206982), focused on the safe, evidence-based, ethical and responsible implementation of artificial intelligence in medicine. ISMAI organises the International Symposium on Medical AI, its flagship scientific meeting, bringing together clinicians, AI scientists, researchers, ethicists, legal scholars, policymakers and healthcare leaders.
Source: International Society of Medical AI
0 Comments
Latest on Rezul News
- Jade Promenade to Hold Groundbreaking Ceremony in Las Vegas Chinatown on December 8th
- Oklahoma Roofing Company Explains Why a Leak-Free Roof May Still Need Repairs
- Developers break ground on new Hilton dual-brand hotel in Naples
- Developer Daniel Kaufman Says Voters Paid for Housing but Kept the Rules That Slow It Down
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Kitchen Table Economics: An Invitation to Think Differently
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- Denver Real Estate Meetup Closes Sixth Year With Free Investor Holiday Party Dec. 9
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Denver Senior Real Estate Specialist and Elder Law Attorney Share 6 Legal Tips Every Senior Homeowner Should Know
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- Study of 2,993 Google Searches Finds Americans Fear Mold Damage Their Homes More Than Health Risks
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Florida Raises the Homestead Exemption: What Amendment 3 Changes for Homeowners
- First-Time Home Buyers in Austin: NAR Says the Typical First-Time Buyer Is 40 With 9% Down

